Clinical study on the mechanism of blood reflux prevention of Surplug CL

Clinical study on the mechanism of blood reflux prevention of Surplug CL - Clinical study on the mechanism of blood reflux prevention of Surplug CL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031932

Enrollment

Registered

2018-03-27

Start date

2018-03-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with peripheral IV catheters

Interventions

3-way-stopcock Group Extension tube with 3-way-stopcock Group n=20 Surplug CL Group Surplug CL Extension tube Group n=20

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with peripheral IV catheter

Exclusion criteria

Exclusion criteria: Patients who are planned to receive anticoagulant or thrombolysis. Patients who have a history of hypersensitivity reactions to heparin. Patients who are pregnant,breast-feeding or potentially pregnant. Other patients assessed "not applicable" by doctors.

Design outcomes

Primary

Measure	Time frame
Ratio of potency 4 days after the heparin flush Frequency of adverse events Nurse questionnaire survey	—

Secondary

Measure	Time frame
Lengths of catheterization Reasons for interruption Existence of thrombosis (macroscopic observation)	—

Countries

Japan

Contacts

Public ContactHideaki Mizuno

Mejiro Second General Hospital Department of Surgery

zbm05143@sky.zero.ad.jp042-553-3511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026